Grace Therapeutics (GRCE) Live Share Price, Invest From India

Grace Therapeutics Stock Performance

as on October 30, 2026 at 2:21 am IST

Day's Low
Day's High
$1.99
Day's Price Range
$2.03
$2.02
1.49%
Downside
0.50%
Upside
52 Week's Low
52 Week's High
$1.67
52-Week Price Range
$5.18
$2.02
17.33%
Downside
156.44%
Upside

Grace Therapeutics share price movements today

Previous Close: $2.01
Open: $1.99
Volume: 65.6K
Market Cap: $39.3M
Day's Low - High: $1.99 - $2.03
52 Week Low - High: $1.67 - $5.18

Grace Therapeutics Historical Returns

1 Month Return: -4.74 %
3 Month Return: -3.37 %
1 Year Return: -35.78 %
3 Year Return: 0 %
5 Year Return: 0 %

Grace Therapeutics Stock Fundamentals & Key Indicators

Check Grace Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.3M

EPS (TTM)

-1.2557

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.49

Industry PE ratio

-2.82

PEG Ratio

0.01

EBITDA

-25.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-35.78%

Grace Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Grace Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Grace Therapeutics	Buy	$39.3M	NA	-1.49	0.00%	0.00%
Moderna	Neutral	$83.0B	-37.96%	-26.06	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.1B	186.43%	30.08	86.04%	0.00%
Regeneron	Buy	$84.0B	27.09%	19.49	84.86%	0.45%

Stock Returns calculator for Grace Therapeutics Stock including INR - Dollar returns

The Grace Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Grace Therapeutics investment value today

Current value as on today

₹69,532

Returns

-₹30,468

(-30.47%)

Returns from Grace Therapeutics Stock

-₹35,463 (-35.46%)

Dollar Impact

₹4,995 (+4.99%)

Analyst Recommendation on Grace Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Grace Therapeutics. Average target price of $4

Grace Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Grace Therapeutics.

Current Price

$2.02

Analyzed by

1 Analysts

High

Low

Grace Therapeutics target price $0, a slight upside of 0% compared to current price of $2.02. According to 1 analysts rating.

Indian Investors' Interest in Grace Therapeutics Stock

Search interest for Grace Therapeutics Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 29, 2026 to October 29, 2026

Change:8% versus previous 30 day period

Grace Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	0	-
Operating Income	-4	-6	-4	-5	-4	-3	-3	-3	-3	-15
EBITDA	-4	-6	-4	-5	-4	-3	-3	-3	-3	-15
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-4	-4	-	0	-3	-1	-3	-2	-15
Income Tax Expense	-1	0	0	0	-1	-	-	-	-1	-
Net Income	-4	-3	-3	-5	0	-3	-1	-3	-1	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Grace Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Revenue	-	-	-	-	0	-	-	-	-	-
Gross Profit	-2	-2	-	-	0	-	-	-	-	-
Operating Income	-10	-15	-34	-48	-25	-19	-70	-17	-23	-11
EBITDA	-7	-14	-36	-47	-15	-19	-24	-15	-23	-11
Interest Expense	0	0	1	0	0	-	-	-	-	-
Depreciation	2	2	2	3	1	-	0	0	0	0
Income Before Tax	-10	-16	-39	-50	-31	-13	-70	-19	-18	-9
Income Tax Expense	0	-	-	-	-	0	-12	-2	-4	-1
Net Income	-10	-16	-39	-50	-31	-12	-57	-17	-13	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	61.22%	0.00%	0.00%	0.00%	0.00%	0.00%

Grace Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-3	-2	-3	-4	0	-3	0	-2	-1	-15
Operating Cash Flow	-2	-3	-4	-4	-2	-1	-3	-2	-1	-3
Investing Cash Flow	6	0	-	0	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	14	0	0	4	0	-
Change in Cash	4	-3	-4	-4	11	-2	-3	1	-1	-3

Grace Therapeutics Annual Cash Flow

All numbers in Millions USD

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Net Income	-10	-16	-39	-36	-24	-9	-42	-12	-9	-7
Operating Cash Flow	-6	-9	-24	-32	-17	-17	-15	-12	-14	-8
Investing Cash Flow	6	0	-9	11	-12	-3	13	0	-	-
Financing Cash Flow	6	8	45	18	74	-	0	7	14	3
Change in Cash	-2	-1	10	-3	46	-20	-2	-4	0	-5

Global Institutional Holdings in Grace Therapeutics

Check out the Institutions with significant holdings in Grace Therapeutics.

Funds	Holdings
VANGUARD INDEX FUNDS	1.90%
Vanguard	1.90%
iShares	0.18%
Fidelity Concord Street Trust	0.03%
VANGUARD VALLEY FORGE FUNDS	0.01%

Insights on Grace Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, GRCE stock has moved up by 5.0%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 767.1% return, outperforming this stock by 802.9%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 197.8% return, outperforming this stock by 214.1%

About Grace Therapeutics

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.

Organisation	Grace Therapeutics
Headquarters	103 Carnegie Center, Princeton, NJ, 08540, US
Industry	Biotechnology
CEO	Prashant Kohli

Key Management of Grace Therapeutics

Name	Title
Mr. Robert J. DelAversano CPA	VP of Finance and Principal Financial & Accounting Officer
Dr. R. Loch MacDonald M.D., Ph.D.	Member of Scientific Advisory Board & Chief Medical Officer
Mr. Prashant Kohli	CEO & Director
Mr. Amresh Kumar Ph.D.	VP of Program Management
Ms. Carrie D'Andrea	Consultant

FAQs

What is Grace Therapeutics share price today?

Grace Therapeutics share price today is $2.02 as on October 29, 2026 at 8:51 pm IST. Grace Therapeutics share today touched a day high of $2.03 and a low of $1.99.

What is the 52 week high and 52 week low for Grace Therapeutics share?

Grace Therapeutics share touched a 52 week high of $5.18 on April 2, 2026 and a 52 week low of $1.67 on October 26, 2026. Grace Therapeutics stock price today i.e. October 29, 2026 at 8:51 pm IST is trending at $2.02,which is 61.00% down from its 52 week high and 20.96% up from its 52 week low.

What is Grace Therapeutics's market capitalisation today?

Grace Therapeutics market capitalisation is $0.00T as on October 29, 2026 at 8:51 pm IST.

How to invest in Grace Therapeutics Stock (GRCE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Grace Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Grace Therapeutics Stock (GRCE) from India?

Indian investors can start investing in Grace Therapeutics (GRCE) shares with as little as ₹95.25 or $1 (as of October 29, 2026 at 9:06 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.50 in Grace Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 29, 2026 at 9:06 pm IST). Based on Grace Therapeutics share’s latest price of $2.02 as on October 29, 2026 at 8:51 pm IST, you will get 4.9505 shares of Grace Therapeutics. Learn more about fractional shares .